Phibro Animal Health Corporation (PAHC)
收市後：
| 前收市價 | 16.70 |
| 開市 | 16.77 |
| 買盤 | 16.30 x 100 |
| 賣出價 | 16.40 x 100 |
| 今日波幅 | 16.34 - 17.08 |
| 52 週波幅 | 9.40 - 17.08 |
| 成交量 | |
| 平均成交量 | 160,111 |
| 市值 | 662.234M |
| Beta 值 (5 年，每月) | 0.74 |
| 市盈率 (最近 12 個月) | 44.19 |
| 每股盈利 (最近 12 個月) | 0.37 |
| 業績公佈日 | 2024年5月08日 |
| 遠期股息及收益率 | 0.48 (2.87%) |
| 除息日 | 2024年3月05日 |
| 1 年預測目標價 | 10.75 |
ZacksPhibro (PAHC) Moves 31.8% Higher: Will This Strength Last?
Phibro (PAHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
- Reuters
Zoetis to sell medicated feed additive portfolio to Phibro in $350 mln deal
Top animal health company Zoetis Inc will sell its medicated feed additive portfolio and certain other assets to animal nutrition company Phibro Animal Health in a $350 million deal, the two companies said on Sunday. The agreement would also involve some of Zoetis' water soluble products and six manufacturing sites across the U.S., Italy and China, the firms said in a statement. More than 300 Zoetis employees across manufacturing, distribution and commercial activities would transition to Phibro Animal Health, they said.
ZacksShould Value Investors Buy Phibro Animal Health (PAHC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
